The essential role of the transporter ABCG2 in the pathophysiology of erythropoietic protoporphyria

Pengcheng Wang, Madhav Sachar, Jie Lu, Amina I. Shehu, Junjie Zhu, Jing Chen, Ke Liu, Karl Anderson, Wen Xie, Frank J. Gonzalez, Curtis D. Klaassen, Xiaochao Ma

Research output: Contribution to journalArticle

Abstract

Erythropoietic protoporphyria (EPP) is an inherited disease caused by loss-of-function mutations of ferrochelatase, an enzyme in the heme biosynthesis pathway that converts protoporphyrin IX (PPIX) into heme. PPIX accumulation in patients with EPP leads to phototoxicity and hepatotoxicity, and there is no cure. Here, we demonstrated that the PPIX efflux transporter ABCG2 (also called BCRP) determines EPP-associated phototoxicity and hepatotoxicity. We found that ABCG2 deficiency decreases PPIX distribution to the skin and therefore prevents EPP-associated phototoxicity. We also found that ABCG2 deficiency protects against EPP-associated hepatotoxicity by modulating PPIX distribution, metabolism, and excretion. In summary, our work has uncovered an essential role of ABCG2 in the pathophysiology of EPP, which suggests the potential for novel strategies in the development of therapy for EPP.

Original languageEnglish (US)
Article numbereaaw6127
JournalScience Advances
Volume5
Issue number9
DOIs
StatePublished - Sep 18 2019

Fingerprint

transporter
efflux
excretion
biosynthesis
metabolism
mutations
enzymes
therapy

ASJC Scopus subject areas

  • General
  • Physics and Astronomy (miscellaneous)

Cite this

Wang, P., Sachar, M., Lu, J., Shehu, A. I., Zhu, J., Chen, J., ... Ma, X. (2019). The essential role of the transporter ABCG2 in the pathophysiology of erythropoietic protoporphyria. Science Advances, 5(9), [eaaw6127]. https://doi.org/10.1126/sciadv.aaw6127

The essential role of the transporter ABCG2 in the pathophysiology of erythropoietic protoporphyria. / Wang, Pengcheng; Sachar, Madhav; Lu, Jie; Shehu, Amina I.; Zhu, Junjie; Chen, Jing; Liu, Ke; Anderson, Karl; Xie, Wen; Gonzalez, Frank J.; Klaassen, Curtis D.; Ma, Xiaochao.

In: Science Advances, Vol. 5, No. 9, eaaw6127, 18.09.2019.

Research output: Contribution to journalArticle

Wang, P, Sachar, M, Lu, J, Shehu, AI, Zhu, J, Chen, J, Liu, K, Anderson, K, Xie, W, Gonzalez, FJ, Klaassen, CD & Ma, X 2019, 'The essential role of the transporter ABCG2 in the pathophysiology of erythropoietic protoporphyria', Science Advances, vol. 5, no. 9, eaaw6127. https://doi.org/10.1126/sciadv.aaw6127
Wang, Pengcheng ; Sachar, Madhav ; Lu, Jie ; Shehu, Amina I. ; Zhu, Junjie ; Chen, Jing ; Liu, Ke ; Anderson, Karl ; Xie, Wen ; Gonzalez, Frank J. ; Klaassen, Curtis D. ; Ma, Xiaochao. / The essential role of the transporter ABCG2 in the pathophysiology of erythropoietic protoporphyria. In: Science Advances. 2019 ; Vol. 5, No. 9.
@article{7f77d0dbe86347c891f87b20ea69c79a,
title = "The essential role of the transporter ABCG2 in the pathophysiology of erythropoietic protoporphyria",
abstract = "Erythropoietic protoporphyria (EPP) is an inherited disease caused by loss-of-function mutations of ferrochelatase, an enzyme in the heme biosynthesis pathway that converts protoporphyrin IX (PPIX) into heme. PPIX accumulation in patients with EPP leads to phototoxicity and hepatotoxicity, and there is no cure. Here, we demonstrated that the PPIX efflux transporter ABCG2 (also called BCRP) determines EPP-associated phototoxicity and hepatotoxicity. We found that ABCG2 deficiency decreases PPIX distribution to the skin and therefore prevents EPP-associated phototoxicity. We also found that ABCG2 deficiency protects against EPP-associated hepatotoxicity by modulating PPIX distribution, metabolism, and excretion. In summary, our work has uncovered an essential role of ABCG2 in the pathophysiology of EPP, which suggests the potential for novel strategies in the development of therapy for EPP.",
author = "Pengcheng Wang and Madhav Sachar and Jie Lu and Shehu, {Amina I.} and Junjie Zhu and Jing Chen and Ke Liu and Karl Anderson and Wen Xie and Gonzalez, {Frank J.} and Klaassen, {Curtis D.} and Xiaochao Ma",
year = "2019",
month = "9",
day = "18",
doi = "10.1126/sciadv.aaw6127",
language = "English (US)",
volume = "5",
journal = "Indian Journal of Pure and Applied Physics",
issn = "0019-5596",
publisher = "National Institute of Science Communication and Information Resources (NISCAIR)",
number = "9",

}

TY - JOUR

T1 - The essential role of the transporter ABCG2 in the pathophysiology of erythropoietic protoporphyria

AU - Wang, Pengcheng

AU - Sachar, Madhav

AU - Lu, Jie

AU - Shehu, Amina I.

AU - Zhu, Junjie

AU - Chen, Jing

AU - Liu, Ke

AU - Anderson, Karl

AU - Xie, Wen

AU - Gonzalez, Frank J.

AU - Klaassen, Curtis D.

AU - Ma, Xiaochao

PY - 2019/9/18

Y1 - 2019/9/18

N2 - Erythropoietic protoporphyria (EPP) is an inherited disease caused by loss-of-function mutations of ferrochelatase, an enzyme in the heme biosynthesis pathway that converts protoporphyrin IX (PPIX) into heme. PPIX accumulation in patients with EPP leads to phototoxicity and hepatotoxicity, and there is no cure. Here, we demonstrated that the PPIX efflux transporter ABCG2 (also called BCRP) determines EPP-associated phototoxicity and hepatotoxicity. We found that ABCG2 deficiency decreases PPIX distribution to the skin and therefore prevents EPP-associated phototoxicity. We also found that ABCG2 deficiency protects against EPP-associated hepatotoxicity by modulating PPIX distribution, metabolism, and excretion. In summary, our work has uncovered an essential role of ABCG2 in the pathophysiology of EPP, which suggests the potential for novel strategies in the development of therapy for EPP.

AB - Erythropoietic protoporphyria (EPP) is an inherited disease caused by loss-of-function mutations of ferrochelatase, an enzyme in the heme biosynthesis pathway that converts protoporphyrin IX (PPIX) into heme. PPIX accumulation in patients with EPP leads to phototoxicity and hepatotoxicity, and there is no cure. Here, we demonstrated that the PPIX efflux transporter ABCG2 (also called BCRP) determines EPP-associated phototoxicity and hepatotoxicity. We found that ABCG2 deficiency decreases PPIX distribution to the skin and therefore prevents EPP-associated phototoxicity. We also found that ABCG2 deficiency protects against EPP-associated hepatotoxicity by modulating PPIX distribution, metabolism, and excretion. In summary, our work has uncovered an essential role of ABCG2 in the pathophysiology of EPP, which suggests the potential for novel strategies in the development of therapy for EPP.

UR - http://www.scopus.com/inward/record.url?scp=85072343461&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85072343461&partnerID=8YFLogxK

U2 - 10.1126/sciadv.aaw6127

DO - 10.1126/sciadv.aaw6127

M3 - Article

C2 - 31555729

AN - SCOPUS:85072343461

VL - 5

JO - Indian Journal of Pure and Applied Physics

JF - Indian Journal of Pure and Applied Physics

SN - 0019-5596

IS - 9

M1 - eaaw6127

ER -